PHARMAUST Limited ceo Richard Hopkins (pictured) has been appointed as the new managing director of listed bio-pharmaceutical firm Zelda Therapeutics.
Hopkins will take up his new role from 01 Jul, and will "assist Zelda in its strategic development as the company enters its next phase of growth in what has become one of the fastest growing global sectors, medicinal cannabis".
Zelda executive chairman Harry Karelis said since Zelda was founded in 2015 it had developed a diverse portfolio of clinical trial activities, with pre-clinical research studying the effect of cannabinoids on diabetes-associated cognitive decline and breast, brain & pancreatic cancer.
Prior to his role at PharmAust, Hopkins was md and co-founder of Phylogica Limited, with a strong portfolio of research publications.
The above article was sent to subscribers in Pharmacy Daily's issue from 23 May 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 May 18
